Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

SoFi Reports Strong Q1 Results, Raises 2025 Full-Year Guidance
SoFi Reports Strong Q1 Results, Raises 2025 Full-Year Guidance
[content-module:CompanyOverview|NASDAQ:SOFI]

SoFi Technologies (NASDAQ: SOFI) has increasingly solidified its status as a transformative player within the financial services industry, leveraging

Hims & Hers Stock Soars on Novo Nordisk Collaboration
Hims & Hers Stock Soars on Novo Nordisk Collaboration

Every once in a while, investors come across some of the best names in a given industry, which then become subject to the best news and developments during a holding period. Today’s best pick

Coca-Cola Company Stock Can Bubble to New Highs This Year
Coca-Cola Company Stock Can Bubble to New Highs This Year
[content-module:CompanyOverview|NYSE:KO]

Coca-Cola’s (NYSE: KO) stock price can bubble to new highs this year because its Q1 results and guidance update show its everywhere-is-local approach to

3 Stocks Lifting 2025 Guidance Despite Market Jitters
3 Stocks Lifting 2025 Guidance Despite Market Jitters

With tariffs causing markets to waver in 2025, many investors were growing worried about the guidance companies would put out. Analysts expect certain stocks not to give guidance for the rest of

3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to Pass
3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to Pass
[content-module:CompanyOverview|NYSE:MMM]

From Scotch tape and Ace bandages to Filtrete air filters and Post-It Notes, 3M Co. (NYSE: MMM) products are often taken for granted in everyday life

3 Stocks Just Announced Intentions to Buyback Near 10% of Shares
3 Stocks Just Announced Intentions to Buyback Near 10% of Shares

Several stocks now have the ability to buy back a very large amount of their shares. Following recent announcements, these stocks can buy back nearly 10% or more of their market cap. This means

Vertiv Crushes Q1 Estimates, Can the Stock Maintain Momentum?
Vertiv Crushes Q1 Estimates, Can the Stock Maintain Momentum?
[content-module:CompanyOverview|NYSE:VRT]

Vertiv Holdings Co. (NYSE: VRT), a leading supplier of critical power and cooling infrastructure for today's data centers, saw its stock value climb

Fizzing Higher: Coca-Cola Is Outperforming Ahead of Earnings
Fizzing Higher: Coca-Cola Is Outperforming Ahead of Earnings
[content-module:CompanyOverview|NYSE:KO]

During turbulent markets, the resilience of select blue-chip stocks shines through, none more so than The Coca-Cola Company (NYSE: KO). This global

Texas Instruments: Earnings Beat, Upbeat Guidance Fuel Recovery
Texas Instruments: Earnings Beat, Upbeat Guidance Fuel Recovery
[content-module:CompanyOverview|NASDAQ:TXN]

Texas Instruments Incorporated (NASDAQ: TXN) delivered a first-quarter financial performance that significantly surpassed analyst expectations

Is the Floor in for Lam Research After Bullish Earnings?
Is the Floor in for Lam Research After Bullish Earnings?
[content-module:CompanyOverview|NASDAQ:LRCX]

Known for being a cyclical industry to begin with, many semiconductor stocks have been down significantly since the summer of 2024. And just as some

Safran Stock: Strong Q1 Results Drive Impressive Rally
Safran Stock: Strong Q1 Results Drive Impressive Rally

Safran shares surged 5.3% on Friday, propelling the French aerospace and defense giant to the top of the CAC 40 index after reporting exceptional first-quarter results. The company posted adjusted

Is Intuitive Surgical a Buy After Volatile Reaction to Earnings?
Is Intuitive Surgical a Buy After Volatile Reaction to Earnings?
[content-module:CompanyOverview|NASDAQ:ISRG]

Shares of Intuitive Surgical Inc. (NASDAQ: ISRG) are leveling off after some volatile price movement around the company’s quarterly earnings. On April

Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings
Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings
[content-module:CompanyOverview|NYSE:JOBY]

Joby Aviation (NYSE: JOBY), a key player in the developing urban air mobility sector, is seeing renewed interest from the market as it approaches its

4 Reasons Enphase Downtrend Won’t End in 2025; 1 That It Will
4 Reasons Enphase Downtrend Won’t End in 2025; 1 That It Will
[content-module:CompanyOverview|NASDAQ:ENPH]

Enphase (NASDAQ: ENPH) is a good company with a solid product that the solar power industry needs. Its microinverter products allow smaller businesses

Genuine Parts: Solid Earnings But Economic Uncertainties Remain
Genuine Parts: Solid Earnings But Economic Uncertainties Remain
[content-module:CompanyOverview|NYSE:GPC]

Genuine Parts Co. (NYSE: GPC) stock is holding on to gains of around 1% after posting a double beat on earnings on Apr. 22. The stock climbed nearly 5%

Dividend King Kimberly-Clark Is a Good Buy in 2025
Dividend King Kimberly-Clark Is a Good Buy in 2025
[content-module:CompanyOverview|NYSE:KMB]

Dividend Kings, like Kimberly-Clark (NYSE: KMB), are generally good stocks to buy and hold because their visible cash flows sustain reliable dividends

Insider Buying in Applied Materials Reaffirms Bullish Outlook
Insider Buying in Applied Materials Reaffirms Bullish Outlook

Wall Street carries on the old saying that one man’s trash can become another man’s treasure, and in today’s market, that saying stands as strong as ever. As the S&P 500 index has undergone an

Take-Two Interactive: A Defensive Play Set to Explode
Take-Two Interactive: A Defensive Play Set to Explode
[content-module:CompanyOverview|NASDAQ:TTWO]

Take-Two Interactive Software, Inc. (NASDAQ: TTWO) is gaining investor attention due to its strong market performance and impressive portfolio

Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
[content-module:CompanyOverview|NASDAQ:CLLS]

Cellectis S.A. (NASDAQ: CLLS) is a clinical-stage biotechnology company focused on developing 'off-the-shelf' cancer immunotherapies using

Retail Data Shows Urgency in Auto Parts: These 3 Stocks Could Win
Retail Data Shows Urgency in Auto Parts: These 3 Stocks Could Win

The new economic environment has shifted to a new view lately, especially as the implications of new trade tariffs rolled out by President Trump start to take effect on both the psychology and

3 Momentum Stocks That Could Soar Post-Market Volatility
3 Momentum Stocks That Could Soar Post-Market Volatility

While the impact of unanticipated tariff policy changes in early April was market-wide, the recovery has been less even. Despite a major rebound following the sell-off, some firms have been

Alcoa’s Solid Earnings Don’t Make Tariff Math Easier for AA Stock
Alcoa’s Solid Earnings Don’t Make Tariff Math Easier for AA Stock

Alcoa Corp. (NYSE: AA) delivered a solid earnings report, but the stock is down about 3% the morning after its first quarter earnings report. Revenue of $3.37 billion was lighter than the $3.58

With a 60%+ Upside, There’s Plenty to Love About Lovesac
With a 60%+ Upside, There’s Plenty to Love About Lovesac
[content-module:CompanyOverview|NASDAQ:LOVE]

Furniture manufacturer Lovesac Co. (NASDAQ: LOVE) has evolved from a gimmicky oversized foam beanbag chair maker to a higher-end furniture brand

Tariff-Resistant Kinder Morgan Is a Good Buy in 2025
Tariff-Resistant Kinder Morgan Is a Good Buy in 2025
[content-module:CompanyOverview|NYSE:KMI]

There are many reasons Kinder Morgan (NYSE: KMI) is a good buy, all of which involve natural gas production and demand.

Natural gas production and

LVMH Stock: Luxury Giant Faces Market Turmoil
LVMH Stock: Luxury Giant Faces Market Turmoil

Bernard Arnault's luxury empire LVMH has experienced significant market turbulence, with its stock plummeting and erasing over 100 billion euros in market capitalization—a staggering 36% decline